Targeted drugs in metastatic colorectal cancer with special emphasis on guidelines for the use of bevacizumab and cetuximab: an Acta Oncologica expert report. [electronic resource]
Producer: 20050927Description: 203-17 p. digitalISSN:- 0284-186X
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Bevacizumab
- Cetuximab
- Chemotherapy, Adjuvant
- Colonic Neoplasms -- drug therapy
- ErbB Receptors -- antagonists & inhibitors
- Humans
- Neoplasm Metastasis
- Rectal Neoplasms -- drug therapy
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.